| 28.91 1.06 (3.81%) | 06-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 34.36 |
1-year : | 40.13 |
| Resists | First : | 29.42 |
Second : | 34.36 |
| Pivot price | 23.82 |
|||
| Supports | First : | 23.12 |
Second : | 19.22 |
| MAs | MA(5) : | 27.17 |
MA(20) : | 23.85 |
| MA(100) : | 16.62 |
MA(250) : | 16.86 |
|
| MACD | MACD : | 2 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 89  |
D(3) : | 89.2 |
| RSI | RSI(14): 74 |
|||
| 52-week | High : | 29.42 | Low : | 10.68 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ OSCR ] has closed below upper band by 1.2%. Bollinger Bands are 126.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 29.33 - 29.45 | 29.45 - 29.55 |
| Low: | 27.02 - 27.16 | 27.16 - 27.28 |
| Close: | 27.61 - 27.84 | 27.84 - 28.03 |
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
Thu, 11 Jun 2026
Is Oscar Health, Inc. (OSCR) A Good Stock To Buy Now? - Insider Monkey
Thu, 11 Jun 2026
Is Oscar Health, Inc. (OSCR) A Good Stock To Buy Now? - Yahoo Finance
Wed, 10 Jun 2026
Oscar Health stock upgraded at Barclays (OSCR:NYSE) - Seeking Alpha
Wed, 10 Jun 2026
Oscar Health (NYSE:OSCR) Shares Gap Up Following Analyst Upgrade - MarketBeat
Tue, 09 Jun 2026
Oscar Health, Inc. $OSCR Shares Acquired by Geode Capital Management LLC - MarketBeat
Tue, 09 Jun 2026
Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On? - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 266 (M) |
| Shares Float | 247 (M) |
| Held by Insiders | 5.3 (%) |
| Held by Institutions | 67.4 (%) |
| Shares Short | 18,390 (K) |
| Shares Short P.Month | 26,160 (K) |
| EPS | -0.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.57 |
| Profit Margin | -0.4 % |
| Operating Margin | 15.1 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | -2.7 % |
| Qtrly Rev. Growth | 52.5 % |
| Gross Profit (p.s.) | 8.68 |
| Sales Per Share | 50.01 |
| EBITDA (p.s.) | 0.14 |
| Qtrly Earnings Growth | 125.5 % |
| Operating Cash Flow | 2,840 (M) |
| Levered Free Cash Flow | 1,630 (M) |
| PE Ratio | -53.53 |
| PEG Ratio | 0 |
| Price to Book value | 5.18 |
| Price to Sales | 0.57 |
| Price to Cash Flow | 2.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|